Zhiru Xiu

471 total citations
17 papers, 358 citations indexed

About

Zhiru Xiu is a scholar working on Molecular Biology, Genetics and Epidemiology. According to data from OpenAlex, Zhiru Xiu has authored 17 papers receiving a total of 358 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Genetics and 5 papers in Epidemiology. Recurrent topics in Zhiru Xiu's work include Autophagy in Disease and Therapy (5 papers), Virus-based gene therapy research (5 papers) and RNA Interference and Gene Delivery (4 papers). Zhiru Xiu is often cited by papers focused on Autophagy in Disease and Therapy (5 papers), Virus-based gene therapy research (5 papers) and RNA Interference and Gene Delivery (4 papers). Zhiru Xiu collaborates with scholars based in China. Zhiru Xiu's co-authors include Xiao Li, Yilong Zhu, Ningyi Jin, Shanzhi Li, Jinbo Fang, Lili Sun, Yaru Li, Chao Shang, Yiquan Li and Yiquan Li and has published in prestigious journals such as Experimental Cell Research, Frontiers in Pharmacology and Journal of Cellular and Molecular Medicine.

In The Last Decade

Zhiru Xiu

17 papers receiving 355 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhiru Xiu China 10 246 72 71 51 51 17 358
Yujing Gao China 12 283 1.2× 89 1.2× 48 0.7× 49 1.0× 35 0.7× 27 434
Biyun Lin China 11 232 0.9× 66 0.9× 51 0.7× 82 1.6× 53 1.0× 21 426
Zi-Hao Wang China 14 186 0.8× 70 1.0× 48 0.7× 39 0.8× 52 1.0× 37 417
Jinbo Fang China 12 279 1.1× 98 1.4× 70 1.0× 49 1.0× 29 0.6× 39 448
Mei Zhao China 12 283 1.2× 88 1.2× 40 0.6× 27 0.5× 31 0.6× 21 477
Kwame Oteng Darko China 8 325 1.3× 83 1.2× 33 0.5× 38 0.7× 40 0.8× 10 509
Yunjia Li China 8 291 1.2× 118 1.6× 52 0.7× 53 1.0× 33 0.6× 12 429
Yanxia Li China 13 291 1.2× 106 1.5× 40 0.6× 29 0.6× 70 1.4× 25 463
Weilian Bao China 14 294 1.2× 68 0.9× 46 0.6× 113 2.2× 82 1.6× 26 523

Countries citing papers authored by Zhiru Xiu

Since Specialization
Citations

This map shows the geographic impact of Zhiru Xiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhiru Xiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhiru Xiu more than expected).

Fields of papers citing papers by Zhiru Xiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhiru Xiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhiru Xiu. The network helps show where Zhiru Xiu may publish in the future.

Co-authorship network of co-authors of Zhiru Xiu

This figure shows the co-authorship network connecting the top 25 collaborators of Zhiru Xiu. A scholar is included among the top collaborators of Zhiru Xiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhiru Xiu. Zhiru Xiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Xiu, Zhiru, Yilong Zhu, Shanzhi Li, et al.. (2023). Betulinic acid inhibits growth of hepatoma cells through activating the NCOA4-mediated ferritinophagy pathway. Journal of Functional Foods. 102. 105441–105441. 12 indexed citations
2.
Xiu, Zhiru, Yiquan Li, Jinbo Fang, et al.. (2023). Inhibitory Effects of Esculetin on Liver Cancer Through Triggering NCOA4 Pathway-Mediation Ferritinophagy in vivo and in vitro. Journal of Hepatocellular Carcinoma. Volume 10. 611–629. 20 indexed citations
3.
Li, Yaru, Zhiru Xiu, Yang Xia, et al.. (2023). Neobavaisoflavone induces pyroptosis of liver cancer cells via Tom20 sensing the activated ROS signal. Phytomedicine. 116. 154869–154869. 25 indexed citations
4.
Yang, Xia V., Bing Bai, Yaru Li, et al.. (2023). Peimisine ameliorates DSS-induced colitis by suppressing Jak–Stat activation and alleviating gut microbiota dysbiosis in mice. Journal of Pharmacy and Pharmacology. 76(5). 545–558. 7 indexed citations
5.
Shang, Chao, Lili Sun, Yiquan Li, et al.. (2022). Ad-VT enhances the sensitivity of chemotherapy-resistant lung adenocarcinoma cells to gemcitabine and paclitaxel in vitro and in vivo. Investigational New Drugs. 40(2). 274–289. 5 indexed citations
6.
Xiu, Zhiru, Yilong Zhu, Yaru Li, et al.. (2022). Caryophyllene Oxide Induces Ferritinophagy by Regulating the NCOA4/FTH1/LC3 Pathway in Hepatocellular Carcinoma. Frontiers in Pharmacology. 13. 930958–930958. 65 indexed citations
7.
Li, Tingyu, Jinbo Fang, Xing Liu, et al.. (2022). In vivo and in vitro inhibition of SCLC by combining dual cancer-specific recombinant adenovirus with Etoposide. Journal of Cancer Research and Clinical Oncology. 148(5). 1073–1085. 6 indexed citations
8.
Li, Yiquan, Chao Shang, Zirui Liu, et al.. (2022). Apoptin mediates mitophagy and endogenous apoptosis by regulating the level of ROS in hepatocellular carcinoma. Cell Communication and Signaling. 20(1). 134–134. 24 indexed citations
9.
Xiu, Zhiru, Yaru Li, Xia Yang, et al.. (2022). Apoptin Inhibits Glycolysis and Regulates Autophagy by TargetingPyruvate Kinase M2 (PKM2) in Lung Cancer A549 Cells. Current Cancer Drug Targets. 24(4). 411–424. 4 indexed citations
10.
Cheng, Cheng, Jinxin Zhang, Jinbo Fang, et al.. (2022). Myricetin activates the Caspase-3/GSDME pathway via ER stress induction of pyroptosis in lung cancer cells. Frontiers in Pharmacology. 13. 959938–959938. 30 indexed citations
11.
Wang, Tongxing, Yue Li, Yiquan Li, et al.. (2022). Apoptin causes apoptosis inHepG‐2 cells via Ca2+imbalance and activation of the mitochondrial apoptotic pathway. Cancer Medicine. 12(7). 8306–8318. 6 indexed citations
12.
Fang, Jinbo, Chao Shang, Yiquan Li, et al.. (2021). Ad-apoptin inhibits glycolysis, migration and invasion in lung cancer cells targeting AMPK/mTOR signaling pathway. Experimental Cell Research. 409(2). 112926–112926. 20 indexed citations
13.
Li, Yaru, Yilong Zhu, Jinbo Fang, et al.. (2021). Ad-Apoptin-hTERTp-E1a Regulates Autophagy Through the AMPK-mTOR-eIF4F Signaling Axis to Reduce Drug Resistance of MCF-7/ADR Cells. Frontiers in Molecular Biosciences. 8. 763500–763500. 2 indexed citations
14.
Liu, Zirui, Yiquan Li, Yilong Zhu, et al.. (2021). Apoptin induces pyroptosis of colorectal cancer cells via the GSDME-dependent pathway. International Journal of Biological Sciences. 18(2). 717–730. 62 indexed citations
15.
Shang, Chao, Yilong Zhu, Yiquan Li, et al.. (2021). Autophagy promotes oncolysis of an adenovirus expressing apoptin in human bladder cancer models. Investigational New Drugs. 39(4). 949–960. 3 indexed citations
16.
Li, Wenjie, Yiquan Li, Shanzhi Li, et al.. (2020). Anti‐tumour effects of a dual cancer‐specific oncolytic adenovirus on Breast Cancer Stem cells. Journal of Cellular and Molecular Medicine. 25(2). 666–676. 11 indexed citations
17.
Zhang, Huiyuan, Yingna Liu, Zhiru Xiu, et al.. (2018). Ginsenoside Compound K Regulates Amyloid β via the Nrf2/Keap1 Signaling Pathway in Mice with Scopolamine Hydrobromide-Induced Memory Impairments. Journal of Molecular Neuroscience. 67(1). 62–71. 56 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026